PATENT CLAIM ANALYSIS

Application Number: 16148601
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["514", "017800"]

Abstract:
The disclosure pertains to methods of treating or preventing a disease or condition associated with and/or induced by soluble A-beta oligomer such as Alzheimer's disease by administering to a subject in need thereof conformation specific and/or selective antibodies or binding fragments thereof and related products.

Claim (Index 21):
A composition or kit comprising the antibody or binding fragment of  claim 19 , an immunoconjugate comprising said antibody, or a nucleic acid encoding said antibody.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 97.0
- Lexical Diversity: 1.20513
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11304986', '14967260', '13701151', '10642099', '14383602']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7710455726488149
- 35 USC 102 Novelty (BERT): 0.5257748351773192
- Combined Prediction Score: 0.7465184989016653
- Mean Citation Score: 329.930246
- Max Citation Score: 341.01526
- Similarity Product: 250.349216100986

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test